Digest Network Come funziona
Digest / Comunicato

Compatibilità
Salva()
Condividi
Recapiti
Vuoi vedere nel tuo digest i prossimi comunicati di questo professionista?

Comunicati correlati

22/01/2025
Farmaceutica
Politica Internazionale
Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Fonte
INVENTIVA
Emittente
GLOBENEWSWIRE
0
29/01/2025
Farmaceutica
Politica Internazionale
Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology
Fonte
INVENTIVA
Emittente
GLOBENEWSWIRE
0
30/10/2024
Farmaceutica
Politica Internazionale
Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
Fonte
INVENTIVA
Emittente
GLOBENEWSWIRE
0